O
Orchestra BioMed Holdings, Inc.
OBIO · NASDAQ · Healthcare · 264M
Closing price
$5.95
+3.84% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
4.5×
Enterprise value / EBITDAEV/EBITDA
-5.2×
Free cash flow yieldFCF yield
-17.4%
Return on equityROE
-83.2%
Operating margin
-154.7%
Net debt / EBITDAbalance-sheet strength
0.4×
Interest coverage
-45.1×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.